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To identify early adaptive processes of cardiac remodeling (CR) in response to volume overload, we investigated the molecular events that
may link intracellular Ca2 + homeostasis alterations and cardiomyocyte apoptosis. In swine heart subjected to aorto-cava shunt for 6, 12, 24,
48 and 96 h sarcoplasmic reticulum (SR) Ca2 + pump activity was reduced until 48 h ( 30%), but a recovery of control values was found at
96 h. The decrease in SR Ca2 +-ATPase (SERCA2a) expression at 48 h, was more marked ( 60%) and not relieved by a subsequent
recovery, while phospholamban (PLB) concentration and phosphorylation were unchanged at all the considered times. Conversely,
acylphosphatase activity and expression significantly increased from 48 to 96 h ( + 40%). Bcl-2 expression increased significantly from 6 to
24 h, but at 48 h, returned to control values. At 48 h, microscopic observations showed that overloaded myocardium underwent substantial
damage and apoptotic cell death in concomitance with an enhanced Fas/Fas-L expression. At 96 h, apoptosis appeared attenuated, while Fas/
Fas-L expression was still higher than control values and cardiomyocyte hypertrophy became to develop. These data suggest that in our
experimental model, acylphosphatase could be involved in the recovery of SERCA2a activity, while cardiomyocyte apoptosis might be
triggered by a decline in Bcl-2 expression and a concomitant activation of Fas.D 2003 Elsevier B.V. All rights reserved.Keywords: Ca2+ pump; Sarcoplasmic reticulum; Apoptosis; Hypertrophy; Acylphosphatase, Bcl-21. Introduction
Cardiac remodeling (CR) is a widely used term whose
meaning has progressively extended to include the manifold
adaptive processes induced in heart muscle by a variety of
pathological conditions such as the after-effects of myocar-
dial infarction, hypertension, valvular diseases, familial
cardiomyopathies and some hormonal intoxications. Thus,
CR may be considered as a rather complex process which
results from the interaction of mechanical stress with several
other factors, such as ischemia and neurohormonal effects.
The adaptive processes of CR involve changes in gene
expression followed by phenotypic modifications aimed at
recovery of cardiac function. However, in spite of the0925-4439/03/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
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phenotypic changes are often similar since cardiomyocyte
hypertrophy and alterations of intracellular Ca2 + handling
are among the prominent findings [1]. Most attention,
however, has been focused on late changes of CR while
little is known about the initial molecular events that may be
a prelude to the alterations described above. In this connec-
tion, an interesting—and so far unsolved—question regards
the early changes in sarcoplasmic reticulum (SR) activity,
which plays a key role in the intracellular Ca2 + level
regulation, and the relationship between these alterations
and the development of cardiomyocyte apoptosis, a condi-
tion that has been suggested to precede the hypertrophic
response [2,3].
Heart SR contains a Ca2 + pump which transports 2 mol
of calcium ions into the SR lumen by utilizing 1 mol of ATP
as a source of energy during a reaction cycle that involves
the formation of acyl-phosphorylated intermediate (EP). The
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ed by phospholamban (PLB), a 52-residue cardiac SR-
associated protein whose inhibitory effect is removed by
phosphorylation at either Ser-16 or Thr-17 [4]. An addi-
tional regulatory effect on the SR calcium pump might be
exerted by acylphosphatase (ACPase, EC 3.6.1.7), a cyto-
solic enzyme, well represented in cardiac muscle, that
catalyzes the hydrolysis of acylphosphates [5–7]. In previ-
ous studies, we have shown that ACPase can interact with
SERCA2a and actively hydrolyze the EP intermediate of
this transport system, an effect that results in an enhanced
activity of the SR Ca2 + pump [8,9].
Besides their consequences on cardiomyocyte contractile
functioning, intracellular Ca2 + homeostasis alterations have
been consistently related to apoptosis. In this regard, it is
noteworthy that some anti-apoptotic or pro-apoptotic agents,
notably Bcl-2 and Fas, can also affect intracellular Ca2 +
distribution. Bcl-2, is a 26-kDa protein localized, in addition
to other cellular districts, in the endoplasmic reticulum (ER).
In different cell types, the anti-apoptotic effect of this
protein seems to depend, at least in part, on its ability to
regulate Ca2 + fluxes, thus preventing an excessive ER Ca2 +
pool depletion and a sustained cytosolic Ca2 + increase
[10,11]. A similar effect of Bcl-2 on cardiac SR Ca2 +
transport is conceivable, all the more so since it would fit
with the well known association between the changes in SR
activity and cardiac hypertrophy [12]. Fas (APO-1/CD95) is
a transmembrane receptor belonging to the TNF receptor
superfamily [13], constitutively present in myocytes. It is
upregulated in relation to diastolic stress [14] and the
interaction with its specific ligand (Fas-L) [15] results in
cell-specific responses, including modification of intracel-
lular Ca2 + levels and apoptosis [16,17].
Based on this background, we decided to investigate
some of the earliest aspects of CR, notably the molecular
events which might represent a link between intracellular
Ca2 + homeostasis alterations and cardiomyocyte apoptosis.
In this connection, we have previously reported some
biochemical changes occurring in heart muscle during the
first 96 h of a pressure overload imposed by aortic banding
[18]. With the aim to detect further molecular aspects of
early CR, the present paper regards a study about the effects
of volume overload, a condition whose morpho-functional
adaptations are rather different from those observed in
response to pressure overload [19]. Swine hearts, whose
anatomo-functional characteristics are similar to those of the
human heart, were subjected to volume overload by aorta-
cava shunt for 6, 12, 24, 48 and 96 h in order to detect the
short-term biochemical changes occurring in the left ven-
triculum (LV). In particular, we analyzed: (1) SERCA2a
activity and expression and the relationship between the
levels of this ionic pump and those of its known or potential
regulators: PLB and ACPase; (2) the expressions of Bcl-2,
Fas and Fas-L as possible determinants of altered Ca2 +
handling as well as of cardiomyocyte apoptosis. These
assays paralleled hemodynamic and echocardiographicmeasurements, to assess the changes in cardiac function
and anatomy, and the microscopic observations aimed to
detect the cellular alterations induced by our volume over-
load conditions.2. Materials and methods
2.1. Experimental model
The experimental protocol described in the study con-
forms with the Guide for the Care and Use of Laboratory
Animals published by the US National Institutes of Health
(NIH Publication No. 85-23, revised 1996). Farm pigs
(n = 24; four for each group), fasting overnight, weighing
30–45 kg, were used. Animals were premedicated with
intramuscular ketamine (15 mg/kg) and diazepam (1 mg/
kg). Anesthesia was induced with ketamine (0.5 mg/kg) and
atropine (0.5 mg/kg) and the pigs were subsequently intu-
bated and ventilated with oxygen supplemented with 50%
N2O and fluothane at 1–1.5%. Pancuronium bromide (0.1
mg/kg) was given at the beginning of the surgical proce-
dure. The abdomen was opened via a midline incision, and
the inferior part of the vena cava and abdominal aorta distal
to the renal arteries were cleaned of fat and adventitia. The
shunt was performed using a Dacron prosthesis (8 mm
diameter) which was sutured latero–laterally to the abdom-
inal aorta and to the inferior vena cava using partial
occluding clamps. When the anastomosis was performed,
the clamps were released, hemostasis was obtained and the
abdomen was closed. At the time of sacrifice, which was at
6, 12, 24, 48 and 96 h after surgery, the animals were again
anesthetized, subjected to hemodynamic and echocardio-
graphic measurements and then killed using humanitarian
methods. After sacrifice, specimens of myocardial tissue
from the LV were taken for biochemical and histological
evaluation. Control animals were simply anesthetized for
hemodynamic and echocardiographic measurements and
immediately sacrificed.
2.2. Hemodynamic and echocardiographic measurements
Two 6F pigtail catheters were introduced into the left
femoral artery and advanced to monitor left ventricular and
descending aortic pressure. A Swan–Ganz catheter was
advanced from an external jugular vein to the pulmonary
artery to measure pulmonary capillary wedge pressure and
cardiac output (thermodilution). Two-dimensional and M-
mode echocardiographic studies (2.25/3.5 mHz transducer,
SIM 5000) and relative measurements were performed on
the right parasternal area and recorded on videotape [19];
wall thicknesses were measured according to the recom-
mendations of the American Society for Echocardiography
[20]. Left ventricular mass (LVM) was calculated using a
validated formula [21]. Measurements were analyzed inde-
pendently by two experienced echocardiographers. Inter-
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and 2.5F 0.3% for cavity size and 3.7F 0.4% and
2.1F 0.3% for wall thickness, respectively.
2.3. Ca2+-ATPase activity and Ca2+ uptake measurements
Sarcoplasmic reticulum vesicles (SRVs), purified from
cardiac LV specimens, were measured for protein [22] and
used to assay Ca2 +-ATPase activity and Ca2 + uptake as
previously reported [18].
Ca2 +-dependent ATPase activity was calculated by sub-
tracting the basal ATPase activity (in the presence of 1 mM
Tris–EGTA) from the total Ca2 +-ATPase (in presence of 10
AM Ca2 +-free). Reactions were started with ATP, and after
stopping, the amount of released Pi was measured by
malachite green procedure [23]. 45Ca uptake was measured
as the difference between 45Ca influx into vesicle at time 0
and at the end of incubation (30 s). The vesicles were
separated by filtration through a Millipore filter (0.45 Am
pore size) and the filter-trapped radioactivity was deter-
mined by liquid scintillation spectroscopy.
2.4. ACPase activity measurement
Cardiac LV specimens were homogenized in 0.1 M HCl,
adjusted to pH 7 and centrifuged. The supernatants were
assayed for protein and for activity. ACPase activity was
measured by a continuous optical test at 283 nm, using
benzoyl phosphate as substrate [24]. Benzoyl phosphate was
synthesized according to Camici et al. [25].
2.5. Determination of caspase-3 activity
Cardiac samples from control (n = 4) and volume-over-
load hearts (n = 4) were homogenized with a polytron homo-
genizer kept on ice, sonicated and centrifuged at 22000 g
and 4 jC for 10 min. 20 Al of the supernatant were used for
the measurement of the caspase-3 activity by the CaspACE
assay system, colorimetric (Promega, WI, USA). Positive
control was obtained by staurosporine-induction of apoptosis
in cultured rat cardiomyocytes according to Yue et al. [26].
Activity was expressed as nmol of p-nitroaniline (pNA)
released/h/mg protein.
2.6. Western blot analysis of SERCA2a, PLB, Bcl-2, Fas-L
and ACPase
The equivalent of 20 Ag of SRV protein mixtures for each
lane, boiled for SERCA2a and Bcl-2, unboiled for PLB,
were separated, respectively, on 12% and 15% SDS-PAGE
gels. ACPase and Fas-L separation was performed on the
same 15% gel using 40 Ag of boiled supernatant protein
mixtures. The gels were electroblotted to nitrocellulose
membranes that were stained with Ponceau red to confirm
equal loading and transfer. After blocking nonspecific sites
for 2 h in 5% BSA T-TBS solution (50 mM Tris–HCl, pH7.4, 150 mM NaCl, 0.1% Tween 20) the membranes were
exposed to monoclonal (mouse) anti-SERCA2a ATPase
antibody (Affinity Bioreagents Inc., Golden, CO), polyclon-
al (rabbit) anti-ACPase antibody, purified as previously
described [27], monoclonal (mouse) anti-PLB antibody
(Upstate Biotechnology, Lake Placid, NY) and monoclonal
(mouse) anti-Bcl-2 antibody (Oncogene Research product).
For detection, a second antibody, a peroxidase-conjugated
anti-rabbit IgG or anti-mouse IgG (Amersham Pharmacia
Biotech, Italy) and enhanced chemiluminescence assay
(Supersignal West-Dura; Pierce) were used. To detect
PLB-phosphorylation status, the same nitrocellulose used
to reveal PLB protein expression was stripped and reprobed
with 10 Ag/ml monoclonal (mouse) anti-P-Serine16 anti-
body (Sigma-Aldrich, Milano, Italy). Protein expression
levels were quantified by laser densitometry using Quantity
One software (Bio-Rad Laboratories). The data from densi-
tometric analysis were normalized to protein amount loaded
on the PAGE and were identical when these values were
related to tubulin protein levels.
2.7. Transmission electron microscopy
Myocardial biopsies were taken from the LV wall of each
animal, immediately fixed by immersion in cold 2.5%
glutaraldehyde in 0.1 M cacodylate buffer, pH 7.4 at room
temperature, postfixed in 1% osmium tetroxide in 0.1 M
phosphate buffer, pH 7.4 at room temperature and routinely
processed for ultrastructural analysis. Semithin sections, 2
Am thick, were cut and stained with toluidine blue–sodium
tetraborate and observed under light microscope. Ultrathin
sections obtained from the same specimens were placed on
200-mesh copper grids and stained with uranyl acetate and
alkaline bismuth subnitrate. Approximately 200 tissue sec-
tions from control and volume-overloaded myocardium
were examined under a transmission electron microscope
(TEM) (JEOL 1010). In particular, three independent ultra-
thin sets (grids) were observed for each biopsy.
2.8. Immunofluorescence analyses
Immunostaining for Fas was performed on 4-Am-thick
cryosections. The tissue sections of control and volume
overload hearts were incubated with 5 Ag/ml of polyclonal
(rabbit) anti-Fas antibodies (FAS-M20, Santa Cruz) and the
immunoreactivity was detected with (mouse anti-rabbit)
Alexa-488 conjugated secondary antibodies (Molecular
Probes, Eugene OR). Negative controls for the immuno-
reactions were performed by substituting the primary anti-
bodies with nonspecific serum. Counterstaining was
performed using Hoechst 33342 (Molecular Probes) to reveal
chromatin features. Anti-fading glycerol was used as mount-
ing medium. A chilled CCD camera (CROMA, DTA, Italy)
was used to collect images. Dual-channel signal scanning
from nuclei (blue) and Fas (green) was recorded and saved in
two different files. Images were signal-averaged during
Table 1
Hemodynamic and echocardiographic changes after aorta-cava shunt
Hours 0 6 12 24 48 96
Heart rate (beats/min) 82F 5 116F 4* 112F 4* 111F 8* 108F 8* 107F 7*
Aortic systolic pressure (mm Hg) 125F 18 113F 7* 114F 5* 115F 4* 116F 7 117F 7
PWP (mm Hg) 14F 4 22F 5 22.8F 4* 23F 4* 25F 5* 21F 4*
Cardiac output (ml/min) 2009F 463 3213F 417* 3422F 465* 3549F 888* 3370F 503* 3519F 203*
LVESP (mm Hg) 127F 23 121F 5 123F 10 121F11 123F 5 124F 7
LVEDP (mm Hg) 8F 2 13F 2* 14F 3* 14F 2* 15F 2* 10F 2
DWT (mm) 7.8F 0.7 7.4F 0.5 7.6F 0.3 8.0F 0.9 7.9F 0.9 8.1F 0.6
SWT (mm) 11.2F 1 10.9F 0.3 10.9F 0.4 11.1F 0.3 11.1F1.2 11.4F 1.1
LVM (g/kg) 2.69F 0.5 2.72F 0.5 2.70F 0.3 2.71F 0.6 3.01F 0.9 3.15F 0.4*
Values are meansF S.D.
LVESP, left ventricular end-systolic pressure; LVEDP, left ventricular end-diastolic pressure; DWT, diastolic wall thickness; SWT, systolic wall thickness;
LVM, left ventricular mass; PWP, pulmonary wedge pressure.
*P< 0.05 vs. control.
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(five scans) to reduce noise level and improve the quality of
the image.Fig. 1. Time course of SR Ca2 + uptake (A), Ca2 + ATPase (B), and ACPase
activities (C) in control heart (0) and in hearts subjected to volume overload.
All activities are expressed as Amol/min/mg SR vesicle protein. Each value
represents the mean value of four experimentsF S.D. *P< 0.05 vs. control;
yP < 0.05 vs. 24 h; §P< 0.05 vs. 48 h.2.9. Detection of apoptotic cells
In situ end-labeling of nicked DNA (ISEL assay) was
performed on paraffin-embedded sections from control and
volume-overloaded LV as previously reported [28], withFig. 2. Top: representative Western blotting of SERCA2a (A), and PLB (B)
from control heart (0) and hearts subjected to volume overload. Bottom:
quantitative data. Each bar represents the mean valueF S.D. of four different
blots. Signals were quantified by densitometric analysis and are expressed as
a percentage of the control value. No significant changes were observed for
PLB protein expression. *P < 0.05 vs. control; zP< 0.05 vs. 12 h.
Fig. 3. Top: representative Western blotting of ACPase (A) and Bcl-2 (B)
from control heart (0) and hearts subjected to volume overload. Bottom:
quantitative data. Each bar represents the mean valueF S.D. of four
different blots. Signals were quantified by densitometric analysis and are
expressed as a percentage of the control value. *P < 0.05 vs. control;
yP < 0.05 vs. 24 h; §P < 0.05 vs. 48 h.
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first with the Klenow fragment of DNA polymerase I and
biotylinated deoxynucleotides (FRAGEL-Klenow, DNA
fragmentation kit, Calbiochem, CA) and then with strep-
toavidin-peroxidase and finally stained with diaminobenzi-
dine tetrahydrochloride (DAB). Counterstaining was
performed with methyl green. LV Apoptotic nuclei were
easily recognized by the presence of a dark brown staining
in contrast with that of necrotic and mitotic cells which
instead appeared weakly stained. Viable cells appeared
green. The number of viable green-stained as well as of
apoptotic cardiomyocytes in ISEL-stained sections wereFig. 4. Detection of LV Fas expression by immunofluorescence. No
staining was detected in the control myocardium (A). In the myocardial
tissue sections from 48 (B) and 96 h (C) of volume overload, the
immunoreaction appears mostly granular throughout the fibers with a slight
enhancement of subsarcolemmal staining. Note that only after 48 h of
overload (B), is the immunostaining associated with the occurrence of
apoptotic nuclei (arrows) and apoptotic body formation (arrowheads).
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field = 26300 Am2) at 40 . An average of 384 microscop-
ic fields (four in each section for a total of three sections for
each biopsy examined) were analyzed by two different
observers and the individual values were then averaged.
The cardiomyocyte nuclei were identified by the standard
morphological criterion: typical ovoid nucleus included in
the cross-striated cytoplasm of myocardial fibers in trans-
versally oriented section.
2.10. Measurement of cell size
Additional sections from paraffin-embedded tissue were
stained with 1% toluidine-blue. At each experimental time,
10 myocytes from six randomly selected optical fields in
each transversely sectioned specimen (three from each
animal) of 26300 Am2 were analyzed at a magnification
of 40 by Adobe Photoshop Program. The area of indi-
vidual cells containing well-defined round nuclei, were
measured using Scion Image Program.
2.11. Statistics
All data are presented as meanF standard deviation
(S.D.). Comparisons between the different groups were
performed by ANOVA followed by the Bonferroni t-test.
A value of P < 0.05 was accepted as statistically signif-
icant.Fig. 5. TEM of 96-h volume-overloaded (A) and 48-h volume-overloaded (B, C,
quite superimposable to the controls. (B) A prominent intracellular edema associat
myofibrillar disarray consisting in loss of myofilaments (arrows) are shown in
apoptotic features, i.e. highly condensed chromatin clumps against the nuclear en3. Results
3.1. Hemodynamic data
During the study period, the aorta-cava fistula remained
pervious in all the operated pigs and no animal showed signs
of heart failure. The data reported in Table 1 indicate that,
although systolic and diastolic wall thickness was substan-
tially unchanged, our overloaded hearts developed hypertro-
phic response, since 96 h after surgery, their LVM was
significantly higher with respect to the control value. The
changes in cardiac output were consistent with the imposed
overload conditions. No significant modifications were ob-
served for left ventricular end-systolic pressure (LVESP)
while left ventricular end-diastolic pressure (LVEDP), taken
as an index inversely correlated with heart contractility, was
significantly increased 6 h after surgery. After having attained
a maximum level after 48 h of overload, LVEDP decreased
and at 96 h it was not significantly different from the control
value. The changes in LVEDP were similar to those observed
for pulmonary wedge pressure, although at 96 h they were
still over the control level.
3.2. Biochemical data
The early functional changes of SR Ca2 + pump function
were represented by a parallel and progressive decrease in
the rates of Ca2 +-dependent ATP hydrolysis and Ca2 +D) myocardium. (A) Two cardiomyocytes display an ultrastructural pattern
ed with swelling of mitochondria (arrows) is visible in panel B. (C) Signs of
two adjacent cardiomyocytes. (D) A cardiomyocyte nucleus, displaying
velope, is shown.
Fig. 6. Detection of apoptotic cells by ISEL assay of fragmented DNA. (A)
Representative light microscopic micrograph of 48 h volume-overloaded
myocardium. Note that some cardiomyocytes exhibit dark brown-stained
ISEL-positive nuclei. (B) Light microscopic micrograph of control
myocardium. Virtually no cardiomyocyte stain is positive for apoptotic
nuclear fragmentation.
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to about 30% of control values. At 96 h, these activities
were not significantly different from the control value
showing a functional recovery of SR Ca2 + pump function
(Fig. 1A and B). However, SERCA2a protein expression,
assessed by Western blot analysis, reflected only in part the
modifications of Ca2 + pump activity. In fact, it was signif-
icantly reduced after 24 h and, even more, after 48 h of
overload, but this decrease was more marked (about 60%
below the control value) and remained at a low level, in
spite of the recovery of functional SR properties.Table 2
Apoptotic nuclei number/1 mm2 (A) and caspase-3 activity (nmol pNA/h per mg
Hours 0 6 12
A 0.72F 0.15 18.3F 8.82* 16.5F 672*
B 2.55F 0.11 3.07F 0.14* 3.01F 0.09*
Values are meansF S.D.
*P< 0.05 vs. control.The immunochemical detection of PLB in unboiled
protein samples and its densitometric analysis showed no
significant modifications at all the considered times (Fig.
2B). Nor was PLB-phosphorylation status modified, accord-
ing to the immunodetectable signals revealed by using a
specific antibody that exclusively detects PLB at its Ser-16
phosphorylated site (data not shown).
On the other hand, acylphosphatase activity significantly
increased from 48 h of overload reaching at 96 h a mean
level that was about 40% higher than the control value (Fig.
1C). A similar trend was observed for ACPase protein
expression (Fig. 3A).
We also found significant changes in the expression of
Bcl-2. As shown in Fig. 3B, Bcl-2 protein expression in
overloaded hearts increased significantly at 6, 12 and 24
h after surgery, but returned to levels not significantly
different from control values at 48 h.
As for Fas/Fas-L expression, the immunofluorescence
analysis showed that the incubation of myocardial samples
with the anti-Fas mAb resulted in a specific green staining
representing Fas receptor expression, which was detected
not only on the sarcolemma but also within the cytoplasm of
cardiomyocytes exposed to the increased workload (Fig. 4).
The immunostaining, undetectable in the tissue sections of
the control and in the hearts until 24 h of overload, became
clearly evident at 48 h when the co-staining with Hoechst
33342 showed typical apoptotic features (Fig. 4B). After 96
h of overload, Fas expression was still higher than the
control value, but the apoptotic signs disappeared (Fig. 4C).
Western blot analysis of Fas-L showed that the expres-
sion of this protein was revealed in volume-overloaded
hearts compared with undetectable levels in control myo-
cardium (data not shown).
3.3. Morphological data and assessment of cardiomyocyte
apoptosis
Morphological analysis performed in parallel with bi-
ochemical measurements revealed that overloaded myo-
cardium underwent a period of remarkable ventricular
remodeling consisting of the occurrence of several damaged
cardiomyocytes which were focally distributed within the
myocardium. These modifications were evident at 48 h after
surgery and disappeared in the later phases (96 h) of the
experimentation (Fig. 5A–D). Evidence of cardiomyocyte
damage included a prominent intracellular edema accumu-
lation, enlarged nuclei, swollen mitochondria, and in the
appearance of focal areas of sarcomere hypercontractionsprotein) (B)
24 48 96
19.9F 5.96* 34.7F 11.10* 10.9F 5.36*
3.24F 0.13* 5.22F 0.18* 3.41F 0.10*
Table 3
Cardiomyocyte cross-section area (Am2) after aorta-cava shunt
Hours 0 6 12 24 48 96
Am2 225.31F 32.69 249.20F 33.21 252.20F 35.31 266.60F 33.21 280.05F 58.31 425.32F 56.47*
Values are meansF S.D.
*P< 0.05 vs. control.
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Concomitant with the occurrence of these ultrastructural
alterations, evidence of cardiomyocyte apoptosis could also
be observed (Fig. 5D). With the use of ISEL method,
apoptotic nuclei could be easily detected in cardiomyocytes
exposed to 48 h of volume overload (Fig. 6B) compared to
the control (Fig. 6A) and other times (data not shown). The
quantitative analysis of the number of nuclei positively
stained for ISEL confirmed the visual findings, showing a
wave of apoptosis which peaked at 48 h after surgery (Table
2A). In particular, in the 48-h overloaded myocardium, the
number of apoptotic cells represented approximately 12% of
the total number of cardiomyocytes. At 96 h after surgery,
the number of apoptotic nuclei was markedly reduced, at
about 4% of the total number of cardiomyocytes, while a
significant increase in the cross-sectional areas of cardio-
myocytes became evident (Table 3).
The ISEL data about cardiomyocyte apoptosis was
consistent with the time course of caspase-3 activity, which
we measured as a typical biochemical marker of this process
(Table 2B).4. Discussion
The aim of the present investigation was to identify some
aspects of CR, notably the early adaptive processes occur-
ring in heart LV in response to a volume overload. For this
study, we used a well-accepted animal model, swine hearts
subjected to volume overload by an aorta-cava shunt, and an
approach based on the simultaneous survey of hemodynam-
ic, biochemical and morphological changes induced by these
experimental conditions within the first 96 h.
The results of hemodynamic and echocardiographic
measurements indicate a precocious development of a
hypertrophic reaction and a transient loss of contractility
which peaked 24 h after surgery, followed by a progressive
recovery, resulting in the restoration of control values after
96 h. While the hypertrophic response, indicated by the data
regarding LVM, was consistent with the microscopic find-
ings, the time course of the changes in LV contractility
substantially reproduced the observed modification of SR
function, in agreement with several reports from which it
appears that modifications in intracellular Ca2 + handling
play a major role in the adaptation of heart muscle to an
increased working load [29,30]. As regards the factors
responsible for the changes in SR activity, our findings,
notably the absence of a parallelism between the time course
of Ca2 + pump and of SERCA2a protein expression, supportthe involvement of a mechanism acting on the functional
properties rather than on the mass concentration of SR Ca2 +
pump. In this connection, the regulatory role of PLB is well
known and it is accepted that enhanced Ca2 + pump activity
may result either from a decrease in relative PLB/SERCA
ratio or from an increase in PLB phosphorylation status [4].
Our measurements, however, indicate that PLB did not
undergo significant changes in its protein expression nor
in its phosphorylation status at Ser-16 residue, which is the
prerequisite for other residue phosphorylation at all exper-
imental times. These results allow us to exclude a PLB
involvement of in the changes of Ca2 + pump activity in our
overloaded hearts.
Conversely, a novel finding emerging from the present
studies is that ACPase levels gradually rose with respect to
control values and, from 48 h after surgery, this enzyme
exhibited a significant increase not only in its activity but
also in its protein expression. As stated above, ACPase
appears to affect the functional properties of SERCA2a by
stimulating Ca2 + pump activity. Our studies also suggest
that the ACPase effect was mainly due to its hydrolytic
activity on the SR Ca2 + pump EP [8]; however, because of a
structural analogy with PLB, ACPase might also interact
with SERCA2a [9], taking the place of unphosphorylated
PLB and removing the inhibitory effect of this protein, as
recent studies have underlined [31]. In any case, given this
stimulatory effect—in whatever way it is exerted—and the
time course of ACPase levels, it seems reasonable to
propose that our enzyme may be responsible, at least in
part, for the recovery of Ca2 + pump activity.
Another original aspect of our results regards a possible
involvement of Bcl-2 in the controlling of heart SR Ca2 +
transport. Bcl-2 was considered in the present study because
several reports indicate that this protein can regulate the
movements of Ca2 + through ER membrane, notably that
Bcl-2 overexpression leads to increased ER calcium loading
due to an enhancement of Ca2 + uptake [10,11]. In fact,
although the mechanisms for this effect are controversial,
they include a direct interaction with SERCA2a and the
possibility that Bcl-2, as suggested by X-ray and NMR
analysis, could form ionic channels in ER membrane [32].
Based on these findings, and supposing a similar action on
cardiac SR, we measured Bcl-2 protein expression and
found that it was significantly increased over the control
levels after 6, 12 and 24 h of volume overload; these
changes in Bcl-2 expression were temporarily associated
with a decrease in Ca2 + pump activity which, however, was
less marked than the concomitant reduction in SERCA2a
protein levels. Although this finding does not provide
C. Nediani et al. / Biochimica et Biophysica Acta 1638 (2003) 217–226 225evidence for a cause–effect relationship, it should be noted
that at the times in question, both PLB and acylphosphatase
levels were unchanged, thus it seems reasonable to suppose
that lack of correspondence between SERCA2a activity and
protein concentration may be ascribed to an enhanced SR
Ca2 + uptake due to Bcl-2 overexpression. Another property
of Bcl-2, likely related to its action on calcium handling is
its anti-apoptotic function [10,11,32,33], which contrasts
with the pro-apoptotic function of Fas/Fas-L system
[16,17]. In this regard, our overloaded hearts showed signs
of sufferance and of cardiomyocyte apoptosis which, until
24 h, was limited by Bcl-2 overexpression but peaked at 48
h after surgery, just before the hypertrophic response be-
came evident, when Bcl-2 expression returned to control
values and SERCA2a activity and expression reached the
lowest levels. This could contribute to an upregulation of
sarcoplasmic Ca2 + levels, resulting in the activation of
proteases, nucleases and other calcium-dependent enzymes,
a possible cause of the observed morphological changes and
of cardiomyocyte apoptosis [34]. In addition to the reduced
activity of SR Ca2 + pump, another determinant of the
supposed Ca2 + overload, might be represented by Fas
activation. In fact, after 48 h of overload, Fas levels were
enhanced, in agreement to Wollert et al. [14], who report an
overexpression of this receptor in relation with volume
overload. In concomitance with the increased Fas expres-
sion, also Fas-L became detectable in volume-overloaded
hearts, hence the possibility of the activation of this signal-
ing pathway. As suggested by several groups, the manifold
action produced by Fas activation included a prominent
elevation of Ca2 + levels, an effect which is probably
mediated by inositol 1,4,5-triphosphate through a leakage
of Ca2 + from intracellular stores and/or a transmembrane
Ca2 + influx [17]. Fas activation might also be involved in
the development of cardiomyocyte hypertrophy which
appeared in the last phase of our experimental period. This
possibility is suggested by the recent report of Badorff et al.
[35], who found that a functional Fas receptor is required for
the compensatory hypertrophy in response to hemodynamic
overload, and by our findings, which indicate the persis-
tence of high Fas levels even 96 h after surgery.
In conclusion, the results of the present study indicate
that, in our model of volume overload, the early CR re-
sponses involve significant structural and functional changes
which are mainly evident after 48 h but are markedly
attenuated at 96 h. At this time, in particular, SERCA2a
activity was completely restored, which appears to be in
contrast with the late changes observed in chronically failing
hearts, where most reports indicated that the function of this
calcium pump is markedly depressed (B). At present we
cannot provide satisfactory explanation for this discordance,
we only limit to focus that, as above stated, the early
recovery of SERCA2a activity is not attained by changes
in the levels of this protein, but owing to stimulatory effects
that might become exhausted at a later stage. In any case,
although the molecular mechanisms that could link thehemodynamic overload to our findings remain to be eluci-
dated, the results of this study raise two intriguing possibil-
ities. First, the involvement of Bcl-2 and ACPase in the
modulation of SERCA2a activity, notably the role of Bcl-2 in
preventing an excessive reduction during the initial phases of
overload and of ACPase in the subsequent recovery of the
calcium function. Second, the eventuality that cardiomyo-
cyte apoptosis, a prerequisite for the development of cardiac
hypertrophy, is triggered by a decline, until to a return to
basal levels, of Bcl-2 and by a concomitant overexpression
and activation of Fas: a result which might be consistent with
the opposite effects of these agents on heart intracellular
Ca2 + distribution.
In our opinion, further studies would be of interest to
verify these possibilities, and to probe more deeply, even in
different experimental models, their importance for the
adaptive processes of CR.Acknowledgements
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